benzimidazole has been researched along with Colorectal Neoplasms in 2 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Tan, YJ | 1 |
Lee, YT | 1 |
Mancera, RL | 1 |
Oon, CE | 1 |
He, LJ | 1 |
Yang, DL | 1 |
Li, SQ | 1 |
Zhang, YJ | 1 |
Tang, Y | 1 |
Lei, J | 1 |
Frett, B | 1 |
Lin, HK | 1 |
Li, HY | 1 |
Chen, ZZ | 1 |
Xu, ZG | 1 |
2 other studies available for benzimidazole and Colorectal Neoplasms
Article | Year |
---|---|
BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT 116 colorectal cancer cells.
Topics: Apoptosis; Benzimidazoles; Cell Adhesion; Cell Polarity; Colorectal Neoplasms; Gene Expression Regul | 2021 |
Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Pro | 2018 |